Feb. 3 Web Event: Understanding and Addressing Racial Disparities in Cancer Outcomes, Care, and Treatment

The COVID-19 pandemic has raised awareness and intensified discussion of systemic racial disparities in the US healthcare system. These injustices existed well before the pandemic and have been known for decades, but they persist and in some cases have even worsened.

Cancer is consistently recognized as one of the leading causes of death in the country and provides a focal point for a deeper conversation about the many factors that contribute to the racial inequalities we see in cancer outcomes, care and treatment.

KFF and the American Society of Clinical Oncology (ASCO) are hosting a web event featuring oncologists, patient advocates, and policy researchers with expertise in justice and cancer care to explore persistent racial disparities in cancer. Expert panelists will share real-life experiences, provide context on the latest data and discuss a range of actions that could help ensure that all cancer patients receive the highest quality and most equitable cancer care and help eliminate inequalities in cancer outcomes.

Open to the public, the event will include the release of a new KFF briefing, presenting the latest data on racial disparities in cancer and discussing the multiple factors driving them.

panel moderator
Samantha Artiga, Vice President and Director of the Racial Justice and Health Policy Program at KFF

Overview of the latest data on cancer differences
Latoya Hill, Senior Policy Analyst, Racial Justice and Health Policy, KFF

perspectives
Carol Brown, MD, FACOG, FACS, Senior Vice President and Chief Health Equity Officer, Nicholls-Biondi Chair for Health Equity, Memorial Sloan Kettering Cancer Center
Wenora Johnson, Research/Patient Advocate representing the Fight Colorectal Cancer Research Institute and Patient-Centered Outcomes Research Institute
Lori Pierce, MD, FASCO, FASTRO, Professor and Provost of Academic and Faculty Affairs, University of Michigan; Director, Michigan Radiation Oncology Quality Consortium; Chairman of the Board of Directors of the American Society of Clinical Oncology

Audience Q&A with panelists and co-author of upcoming briefing, Michelle Tonge, MD Candidate, UCSF-KFF Health Policy Fellow.

event date

February 3, 2022 at 9:00 am PT/12:00 pm ET

Comments are closed.